Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Tanaka, Toshikazu; Hatakeyama, Shingo; Noro, Daisuke; Togashi, Kyo; Yoneyama, Takahiro; Ohyama, Chikara

Tanaka, Toshikazu; Hatakeyama, Shingo; Noro, Daisuke; Togashi, Kyo; Yoneyama, Takahiro; Ohyama, Chikara.

Afiliación

Tanaka T; Department of Urology, Aomori Prefectural Central Hospital, Aomori, Japan.
Hatakeyama S; Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Noro D; Department of Urology, Mutsu General Hospital, Mutsu, Japan.
Togashi K; Departments of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Yoneyama T; Department of, Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Ohyama C; Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Int J Urol ; 29(5): 476-478, 2022 05.

Article en En | MEDLINE | ID: mdl-35132692

Asunto(s)

Neoplasias de la Próstata; Castración; Terapia Combinada; Humanos; Masculino; Neoplasias de la Próstata/tratamiento farmacológico; Neoplasias de la Próstata/cirugía; Estudios Retrospectivos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans / Male Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google